Veerle Kersemans

2.3k total citations
94 papers, 1.7k citations indexed

About

Veerle Kersemans is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Veerle Kersemans has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Radiology, Nuclear Medicine and Imaging, 33 papers in Molecular Biology and 28 papers in Oncology. Recurrent topics in Veerle Kersemans's work include Radiopharmaceutical Chemistry and Applications (24 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Medical Imaging Techniques and Applications (10 papers). Veerle Kersemans is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (24 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Medical Imaging Techniques and Applications (10 papers). Veerle Kersemans collaborates with scholars based in United Kingdom, Belgium and Canada. Veerle Kersemans's co-authors include Bart Cornelissen, Sean Smart, Philip D. Allen, Véronique Gouverneur, Katherine A. Vallis, Michael Mosley, Ken Kersemans, Ruth J. Muschel, Guido Slegers and Matthew Tredwell and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Veerle Kersemans

93 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veerle Kersemans United Kingdom	25	604	602	458	321	241	94	1.7k
Bart Cornelissen United Kingdom	29	914 1.5×	1.1k 1.8×	948 2.1×	289 0.9×	268 1.1×	112	2.5k
Jelena Levi United States	19	747 1.2×	449 0.7×	336 0.7×	539 1.7×	182 0.8×	36	1.8k
Andreas Faust Germany	25	565 0.9×	278 0.5×	395 0.9×	223 0.7×	382 1.6×	70	1.7k
Il Minn United States	29	786 1.3×	756 1.3×	549 1.2×	292 0.9×	120 0.5×	70	2.2k
Zheng Miao United States	25	723 1.2×	806 1.3×	395 0.9×	471 1.5×	114 0.5×	55	1.7k
Chi‐Wei Chang Taiwan	21	452 0.7×	392 0.7×	222 0.5×	220 0.7×	284 1.2×	60	1.5k
Christopher Cawthorne United Kingdom	22	575 1.0×	321 0.5×	347 0.8×	214 0.7×	305 1.3×	77	1.5k
Raphaël Boisgard France	25	661 1.1×	396 0.7×	305 0.7×	157 0.5×	101 0.4×	55	1.7k
Antero Abrunhosa Portugal	21	467 0.8×	415 0.7×	311 0.7×	147 0.5×	218 0.9×	88	1.4k
Carla F.M. Molthoff Netherlands	32	664 1.1×	1.0k 1.7×	702 1.5×	150 0.5×	287 1.2×	77	2.6k

Countries citing papers authored by Veerle Kersemans

Since Specialization

Citations

This map shows the geographic impact of Veerle Kersemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veerle Kersemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veerle Kersemans more than expected).

Fields of papers citing papers by Veerle Kersemans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veerle Kersemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veerle Kersemans. The network helps show where Veerle Kersemans may publish in the future.

Co-authorship network of co-authors of Veerle Kersemans

This figure shows the co-authorship network connecting the top 25 collaborators of Veerle Kersemans. A scholar is included among the top collaborators of Veerle Kersemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veerle Kersemans. Veerle Kersemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaeppler, Jakob, Jianzhou Chen, Mario Buono, et al.. (2022). Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models. EMBO Reports. 23(9). e53221–e53221. 9 indexed citations

Owen, Joshua, Keiran Logan, Heather Nesbitt, et al.. (2021). Orally administered oxygen nanobubbles enhance tumor response to sonodynamic therapy. SHILAP Revista de lepidopterología. 3(2). 394–401. 20 indexed citations

Jiang, Yanyan, Jennifer Martin, Paul Kinchesh, et al.. (2021). Olaparib increases the therapeutic index of hemithoracic irradiation compared with hemithoracic irradiation alone in a mouse lung cancer model. British Journal of Cancer. 124(11). 1809–1819. 4 indexed citations

Knight, James C., Michael Mosley, Veerle Kersemans, et al.. (2019). Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours. Nuclear Medicine and Biology. 70. 14–22. 18 indexed citations

Kinchesh, Paul, Philip D. Allen, Stuart Gilchrist, et al.. (2019). Reduced respiratory motion artefact in constant TR multi-slice MRI of the mouse. Magnetic Resonance Imaging. 60. 1–6. 5 indexed citations

O’Neill, Eric, Veerle Kersemans, Peter J. Allen, et al.. (2019). Imaging DNA Damage in vivo following [Lu-177] Lu-DOTATATE therapy in a model of pancreatic neuroendocrine cancer. European Journal of Nuclear Medicine and Molecular Imaging. 46. 1 indexed citations

Kersemans, Veerle, Philip D. Allen, Stuart Gilchrist, et al.. (2019). Manganese-free chow, a refined non-invasive solution to reduce gastrointestinal signal for T₁-weighted magnetic resonance imaging of the mouse abdomen. Laboratory Animals. 54(4). 353–364. 1 indexed citations

Wilson, Thomas C., James C. Knight, Stefan Verhoog, et al.. (2018). PET Imaging of PARP Expression Using ¹⁸F-Olaparib. Journal of Nuclear Medicine. 60(4). 504–510. 82 indexed citations

Verhoog, Stefan, Choon Wee Kee, Yanlan Wang, et al.. (2018). ¹⁸F-Trifluoromethylation of Unmodified Peptides with 5-¹⁸F-(Trifluoromethyl)dibenzothiophenium Trifluoromethanesulfonate. Journal of the American Chemical Society. 140(5). 1572–1575. 77 indexed citations

10.

Knight, James C., Michael Mosley, Veerle Kersemans, et al.. (2017). 89Zr-anti-γH2AX-TAT but not 18F-FDG Allows Early Monitoring of Response to Chemotherapy in a Mouse Model of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 23(21). 6498–6504. 21 indexed citations

11.

Kersemans, Veerle, Stuart Gilchrist, Philip D. Allen, et al.. (2015). A resistive heating system for homeothermic maintenance in small animals. Magnetic Resonance Imaging. 33(6). 847–851. 13 indexed citations

12.

Cornelissen, Bart, Veerle Kersemans, Iain D. C. Tullis, et al.. (2011). ErbB-2 Blockade and Prenyltransferase Inhibition Alter Epidermal Growth Factor and Epidermal Growth Factor Receptor Trafficking and Enhance ¹¹¹In-DTPA-hEGF Auger Electron Radiation Therapy. Journal of Nuclear Medicine. 52(5). 776–783. 12 indexed citations

13.

Cornelissen, Bart, Veerle Kersemans, James Thompson, et al.. (2011). Imaging DNA Damage In Vivo Using γH2AX-Targeted Immunoconjugates. Cancer Research. 71(13). 4539–4549. 57 indexed citations

14.

Cornelissen, Bart, et al.. (2009). ¹¹¹ In-Labeled Immunoconjugates (ICs) Bispecific for the Epidermal Growth Factor Receptor (EGFR) and Cyclin-Dependent Kinase Inhibitor, p27 ^Kip1. Cancer Biotherapy and Radiopharmaceuticals. 24(2). 163–173. 11 indexed citations

15.

Kersemans, Veerle, Valentijn Vergote, Indira Madani, et al.. (2008). The Use of [ ¹²³ I]-2-Iodo-L-Phenylalanine as an Early Radiotherapy Evaluation Tool: In Vitro R1M Rabdomyosarcoma Cell and In Vivo Mouse Experiments. Cancer Biotherapy and Radiopharmaceuticals. 23(2). 192–201. 2 indexed citations

16.

Kersemans, Veerle, Bart Cornelissen, Mark D. Minden, Joseph Brandwein, & Raymond M. Reilly. (2008). Drug-Resistant AML Cells and Primary AML Specimens Are Killed by ¹¹¹In-Anti-CD33 Monoclonal Antibodies Modified with Nuclear Localizing Peptide Sequences. Journal of Nuclear Medicine. 49(9). 1546–1554. 32 indexed citations

17.

Kersemans, Veerle, Ken Kersemans, Bart Cornelissen, et al.. (2006). Optimization by Experimental Design of Precursor Synthesis and Radiolabeling of 2-Iodo-L-Phenylalanine, a Novel Amino Acid for Tumor Imaging. Cancer Biotherapy and Radiopharmaceuticals. 21(3). 235–242. 1 indexed citations

18.

Kersemans, Veerle, Bart Cornelissen, John E. Dick, & Raymond M. Reilly. (2006). Indium-111 labeled anti-CD33 monoclonal antibodies (mAbs) modified with nuclear-localizing sequences (NLS) kill mitoxantrone-resistant HL-60 acute myelogenous leukemia (AML) cells. European Journal of Nuclear Medicine and Molecular Imaging. 33. 1 indexed citations

19.

Oltenfreiter, Ruth, Ludovicus Staelens, Soraya Labied, et al.. (2005). Tryptophane-Based Biphenylsulfonamide Matrix Metalloproteinase Inhibitors as Tumor Imaging Agents. Cancer Biotherapy and Radiopharmaceuticals. 20(6). 639–647. 14 indexed citations

20.

Kersemans, Veerle, Ken Kersemans, Bart Cornelissen, et al.. (2004). In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.. European Journal of Nuclear Medicine and Molecular Imaging. 31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact